School of Medicine


Showing 1-27 of 27 Results

  • Andrei Iagaru

    Andrei Iagaru

    Professor of Radiology (Nuclear Medicine)

    Current Research and Scholarly InterestsCurrent research projects include:
    1) PET/MRI and PET/CT for Early Cancer Detection
    2) Targeted Radionuclide Therapy
    3) Clinical Translation of Novel PET Radiopharmaceuticals;

  • David Iberri

    David Iberri

    Clinical Assistant Professor, Medicine - Hematology

    BioDr. Iberri is a hematologist who specializes in the treatment of multiple myeloma, Waldenström macroglobulinemia, and other blood and bone marrow disorders. He is actively involved in clinical research evaluating novel agents in hematologic malignancies. His research interests include the development and application of biomarkers to select patients most likely to benefit from therapy, and in the development of blood tests to reduce the need for bone marrow biopsies in myeloma disease monitoring.

  • Juliana Idoyaga

    Juliana Idoyaga

    Assistant Professor of Microbiology and Immunology

    Current Research and Scholarly InterestsThe Idoyaga Lab is focused on the function and biology of dendritic cells, which are specialized antigen-presenting cells that initiate and modulate our body’s immune responses. Considering their importance in orchestrating the quality and quantity of immune responses, dendritic cells are an indisputable target for vaccines and therapies.

    Dendritic cells are not one cell type, but a network of cells comprised of many subsets or subpopulations with distinct developmental pathways and tissue localization. It is becoming apparent that each dendritic cell subset is different in its capacity to induce and modulate specific types of immune responses; however, there is still a lack of resolution and deep understanding of dendritic cell subset functional specialization. This gap in knowledge is an impediment for the rational design of immune interventions. Our research program focuses on advancing our understanding of mouse and human dendritic cell subsets, revealing their endowed capacity to induce distinct types of immune responses, and designing novel strategies to exploit them for vaccines and therapies.

  • Irogue I Igbinosa

    Irogue I Igbinosa

    Instructor, Obstetrics & Gynecology - Maternal Fetal Medicine
    Masters Student in Epidemiology and Clinical Research, admitted Autumn 2022

    BioIrogue Igbinosa, MD, is a Maternal-Fetal Medicine physician at Stanford University. She is currently an NIH Women's Reproductive Health Scholar (K12), and her research focus includes iron deficiency anemia in pregnancy, severe maternal morbidity and mortality, and health equity.

    She graduated from the University of Houston and earned her medical degree at Baylor College of Medicine. She subsequently completed her residency in Obstetrics and Gynecology Residency at Louisiana State University School of Medicine Baton Rouge. After residency, she was an AAMC-CDC Public Health Policy Fellow able to serve in the CDC Emergency Operations Center and contribute to research for healthcare providers regarding the management of the Zika virus in pregnant persons. She completed her Maternal Fetal Medicine fellowship at Stanford in 2022.

    Dr. Igbinosa is passionate about community-engaged approaches to bridge gaps in evidence-based care for birthing communities and collaborates with local and national policy committees to raise awareness for reproductive justice in maternal health. Her motto is to listen first and serve with compassion.

  • Debra M. Ikeda, M.D.

    Debra M. Ikeda, M.D.

    Professor of Radiology (Breast Imaging), Emerita

    Current Research and Scholarly InterestsMy research interests are mammography positioning, tomosynthesis (DBT) cancer detection and diagnosis, MRI, DWI, MRI-guided breast biopsy, breast cancer recurrence, tattoo/ fiducial/wire localization of axillary lymph nodes, breast cancer and FDG PET-CT imaging, artifical intelligence/deep learning, breast density, density notification legislation, COVID-19 effects on Breast Imaging Centers and personnel

  • Gentaro Ikeda

    Gentaro Ikeda

    Instructor, Medicine - Cardiovascular Medicine

    BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.

  • Jennifer Ikle

    Jennifer Ikle

    Adjunct Clinical Assistant Professor, Pediatrics - Endocrinology and Diabetes

    Current Research and Scholarly InterestsJen is interested in the genetic factors that lead to abnormal beta-cell function and insulin secretion, causing disorders such as hyperinsulinism and neonatal diabetes. Jen’s current research focus is the use of zebrafish models, combined with genetics and genomics, to understand cellular and molecular mechanisms of glucose metabolism and elucidate previously unknown players involved in the regulation of insulin secretion.

  • iva sikirica ilic

    iva sikirica ilic

    Adjunct Clinical Instructor, Educational Programs and Services (EPS)

    BioIva Ilic, MD, is a board certified family physician with extensive experience as a hospitalist. She has a special interest in women's health, small office procedures and preventative care.

    In her spare time, she hikes with her husband, and plays the piano.

  • Daniel Imler

    Daniel Imler

    Clinical Associate Professor, Emergency Medicine
    Clinical Associate Professor, Pediatrics

    Current Research and Scholarly InterestsI am interested in understanding the impact of smart, agile clinical pathways to drive behavior change among providers.

  • John P.A. Ioannidis

    John P.A. Ioannidis

    Professor of Medicine (Stanford Prevention Research), of Epidemiology and Population Health and by courtesy, of Statistics and of Biomedical Data Science

    Current Research and Scholarly InterestsMeta-research
    Evidence-based medicine
    Clinical and molecular epidemiology
    Human genome epidemiology
    Research design
    Reporting of research
    Empirical evaluation of bias in research
    Randomized trials
    Statistical methods and modeling
    Meta-analysis and large-scale evidence
    Prognosis, predictive, personalized, precision medicine and health
    Sociology of science

  • Eric Ip

    Eric Ip

    Clinical Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsMy research interests include the use and abuse of anabolic steroids and other performance enhancing/cognitive enhancing drugs.

  • Wui Ip, MD

    Wui Ip, MD

    Clinical Assistant Professor, Pediatrics

    BioWui Ip, MD is a pediatrician and physician informaticist. He is interested in applying machine learning to support clinical decision making and improve patient care.

  • Steven S Isono

    Steven S Isono

    Clinical Professor, Orthopaedic Surgery

    BioDr. Steven Isono is an Orthopaedic Surgeon specializing in Sports Medicine as well as surgery of the knee and shoulder. He is Board Certified by the American Board of Orthopaedic Surgery in both Orthopaedic Surgery and in Sports Medicine with a Certificate of Added Qualification in Sports Medicine.

    Dr. Isono grew up in the East Bay and graduated as the Valedictorian of Oakland High School during which he participated in Basketball, Baseball, Track and Field with All-State Honors in Gymnastics. He received a BA with Honors in Biochemistry from Harvard University in Cambridge, Massachusetts and wrote his Research Thesis on Erythrocyte Abnormalities in Sickle Cell Anemia. He then received his MD from Northwestern University Medical School in Chicago, Illinois and also performed research on Liver Hepatomas during medical school. His Internship in Plastic and Reconstructive Surgery and Residency in Orthopaedic Surgery were both completed at Stanford with additional training in Microsurgery in Japan at the Kyoto University Hospital and the Tokyo Metropolitan Hospital.

    He is serving as Team Physician and Consultant for the United States Olympic and Paralympic Committee (USOPSC) for Men’s Swimming, Triathlon, Judo, Taekwondo, Track and Field, Men’s Rowing, and Boxing), the National Football League Players Association (NFLPA), the Oakland Panthers (Professional Indoor Football League), and Laney College. He was Team Physician for the Golden State Warriors of the National Basketball Association (NBA) for many years and completed this role in 2019. He is also a consultant for the Special Olympics, Ironman World Triathlon Championships, Dew Tour of Action Sports, and Association of Volleyball Professionals.

    In addition to covering numerous National and International World Championship competitions, he has served as the Orthopedic Surgeon for TEAM USA for the 2015 XVII Pan American Games in Toronto, Canada, the 2016 XXXI Summer Olympic Games in Rio de Janeiro, Brazil, and 2018 Youth Olympic Games in Buenos Aries, Argentina as well as the 2019 XVIII Pan American Games in Lima, Peru. Dr. Isono was appointed the TEAM USA Head Team Physician at the 2021 XXXII Summer Olympic Games in Tokyo, Japan in July 2021 and the 2022 XXIV Winter Olympic Games in Beijing, China.

    Dr. Isono also is a founder of a Non-Profit organization called the One Nation Project located in West Oakland. This program uses sports as an avenue to mentor kids-at-risk and involves kids from lower school through high school. Of his “first class” of kids, 10 of 11 kids graduated high school and college with a few of his “kids” becoming an Astrophysicist, a Financial Consultant, a Deputy Sheriff, and an Attorney.

    Dr. Isono is a member of the American Academy of Orthopaedic Surgeons, American Board of Orthopaedic Surgery, American Orthopaedic Society of Sports Medicine, Olympic Sports Medicine Society, Arthroscopy Association of North America, California Orthopaedic Association, Western Orthopaedic Association, NBA Team Physicians Society, and the American College of Sports Medicine. He also holds the position of an Expert Medical Reviewer for the Medical Board of California.

    Among his many honors, Dr. Isono has earned the “Top Doctors in Sports Medicine” award in the California Magazine, Oakland Magazine, and Bay Area Consumer’s Checkbook, the Patients’ Choice Award for California’s Favorite Physicians, and designated among “America’s Top Orthopedists” and "Sports Medicine Physicians" by Consumer’s Research Council of America.

  • Haruka Itakura, MD, PhD

    Haruka Itakura, MD, PhD

    Assistant Professor of Medicine (Oncology)

    BioDr. Haruka Itakura is an Assistant Professor of Medicine (Oncology) in the Stanford University School of Medicine, a data scientist, and a practicing breast medical oncologist at the Stanford Women’s Cancer Center. She is board-certified in Oncology, Clinical Informatics, Hematology, and Internal Medicine. Her research mission is to drive medical advances at the intersection of cancer and data science, applying state-of-the-art machine learning/artificial intelligence techniques to extract clinically actionable knowledge from heterogeneous multi-scale cancer data to improve patient outcomes. Her ongoing research to develop robust methodologies and apply cutting-edge techniques to analyze complex cancer big data was catapulted by an NIH K01 Career Development Award in Biomedical Big Data Science after obtaining a PhD in Biomedical Informatics at Stanford University. Her cancer research focuses on extracting radiomic (pixel-level quantitative imaging) features of tumors from medical imaging studies and applying machine learning frameworks, including radiogenomic approaches, for the integrative analysis of heterogeneous, multi-omic (e.g., radiomic, genomic, transcriptomic) data to accelerate discoveries in cancer diagnostics and therapeutics. Her current projects include prediction modeling of survival, treatment response, recurrence, and CNS metastasis in different cancer subtypes; detection of occult invasive breast cancer; and identification of novel therapeutic targets. Her ultimate goal is to be able to translate her research findings back to the clinical setting for the benefit of patients with difficult-to-treat cancers.

  • Michael Iv

    Michael Iv

    Clinical Professor, Radiology

    Current Research and Scholarly InterestsMy clinical and research interests include brain tumor and vascular imaging in both the adult and pediatric populations, incorporating advanced MR imaging techniques and analyses using qualitative and quantitative methods.

  • Rebecca Ivancie

    Rebecca Ivancie

    Clinical Associate Professor, Pediatrics

    Current Research and Scholarly InterestsMedical Education Projects
    - PHM Fellows and their training in Community Pediatric Hospital Medicine

    Clinical Research: Using PHIS database to study MIS-C and Kawasaki disease